Standardizing Measurement of Chronic Obstructive Pulmonary Disease Exacerbations Reliability and Validity of a Patient-reported Diary

被引:140
作者
Leidy, Nancy K. [1 ]
Wilcox, Teresa K.
Jones, Paul W. [2 ]
Roberts, Laurie
Powers, John H. [3 ]
Sethi, Sanjay [4 ]
机构
[1] UBC, Ctr Hlth Outcomes Res, Bethesda, MD 20814 USA
[2] Univ London St Georges Hosp, London, England
[3] George Washington Univ, Washington, DC USA
[4] SUNY Buffalo, Buffalo, NY 14260 USA
关键词
exacerbation; COPD; symptoms; diary; patient-reported outcomes; CHRONIC-BRONCHITIS; COPD; DIAGNOSIS; OUTCOMES;
D O I
10.1164/rccm.201005-0762OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale: Although exacerbations are an important problem in chronic obstructive pulmonary disease (COPD) and a target of intervention, there is no valid, standardized tool for assessing their frequency, severity, and duration. Objectives: This study tested the properties of the Exacerbations of Chronic Pulmonary Disease Tool (EXACT), a new patient-reported outcome diary. Methods: A prospective, two-group, observational study was conducted in patients with COPD. The acute group (n = 222) was enrolled during a clinic visit for exacerbation with follow-up visits on Days 10, 29, and 60. The stable group (n = 188), recruited by telephone or during routine visits, was exacerbation free for at least 60 days. Measurements and Main Results: Acute patients completed the diary on Days 1-29 and 60-67; stable patients for 7 days. All patients provided stable-state spirometry and completed the St. George Respiratory Questionnaire-COPD (SGRQ-C). Acute patient assessments included clinician and patient global ratings of exacerbation severity and recovery. Mean age of the sample (n = 410) was 65 (+/- 10) years; 48% were male; stable FEV1 was 51% predicted (+/- 20). Internal consistency (Pearson separation index) for the EXACT was 0.92, 1-week reproducibility (stable patients; intraclass correlation) was 0.77. EXACT scores correlated with SGRQ-C (r = 0.64; P < 0.0001) and differentiated acute and stable patients (P < 0.0001). In acute patients, scores improved over time (P < 0.0001) and differentiated between degrees of clinician-rated exacerbation severity (P < 0.05). EXACT change. scores differentiated responders and nonresponders on Day 10, as judged by clinicians or patients (P < 0.0001). Conclusions: Results suggest the EXACT is reliable, valid, and sensitive to change with exacerbation recovery.
引用
收藏
页码:323 / 329
页数:7
相关论文
共 30 条
[1]  
[Anonymous], 2009, FED REGISTER, V74, P65132
[2]   ANTIBIOTIC-THERAPY IN EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].
ANTHONISEN, NR ;
MANFREDA, J ;
WARREN, CPW ;
HERSHFIELD, ES ;
HARDING, GKM ;
NELSON, NA .
ANNALS OF INTERNAL MEDICINE, 1987, 106 (02) :196-204
[3]  
Anzueto A, 2009, Int J Chron Obstruct Pulmon Dis, V4, P245
[4]   Management of acute exacerbations of chronic obstructive pulmonary disease: A summary and appraisal of published evidence [J].
Bach, PB ;
Brown, C ;
Gelfand, SE ;
McCrory, DC .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (07) :600-620
[5]   COPD exacerbations: definitions and classifications [J].
Burge, S ;
Wedzicha, JA .
EUROPEAN RESPIRATORY JOURNAL, 2003, 21 :46S-53S
[6]  
Calverley Peter M A, 2005, COPD, V2, P143
[7]   One-year treatment with mometasone furoate in chronic obstructive pulmonary disease [J].
Calverley, Peter M. A. ;
Rennard, Stephen ;
Nelson, Harold S. ;
Karpel, Jill P. ;
Abbate, Eduardo H. ;
Stryszak, Paul ;
Staudinger, Heribert .
RESPIRATORY RESEARCH, 2008, 9 (1)
[8]   Outcomes for COPD pharmacological trials:: from lung function to biomarkers [J].
Cazzola, M. ;
MacNee, W. ;
Martinez, F. J. ;
Rabe, K. F. ;
Franciosi, L. G. ;
Barnes, P. J. ;
Brusasco, V. ;
Burge, P. S. ;
Calverley, P. M. A. ;
Celli, B. R. ;
Jones, P. W. ;
Mahler, D. A. ;
Make, B. ;
Miravitlles, M. ;
Page, C. P. ;
Palange, P. ;
Parr, D. ;
Pistolesi, M. ;
Rennard, S. I. ;
Moelken, M. P. Rutten-Van ;
Stockley, R. ;
Sullivan, S. D. ;
Wedzicha, J. A. ;
Wouters, E. F. .
EUROPEAN RESPIRATORY JOURNAL, 2008, 31 (02) :416-468
[9]   Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper [J].
Celli, BR ;
MacNee, W ;
Agusti, A ;
Anzueto, A ;
Berg, B ;
Buist, AS ;
Calverley, PMA ;
Chavannes, N ;
Dillard, T ;
Fahy, B ;
Fein, A ;
Heffner, J ;
Lareau, S ;
Meek, P ;
Martinez, F ;
McNicholas, W ;
Muris, J ;
Austegard, E ;
Pauwels, R ;
Rennard, S ;
Rossi, A ;
Siafakas, N ;
Tiep, B ;
Vestbo, J ;
Wouters, E ;
ZuWallack, R .
EUROPEAN RESPIRATORY JOURNAL, 2004, 23 (06) :932-946
[10]   THE SIGNIFICANCE OF RESPIRATORY SYMPTOMS AND THE DIAGNOSIS OF CHRONIC BRONCHITIS IN A WORKING POPULATION [J].
FLETCHER, CM ;
ELMES, PC ;
FAIRBAIRN, AS ;
WOOD, CH .
BMJ-BRITISH MEDICAL JOURNAL, 1959, 2 (AUG29) :257-258